A prospective, randomized clinical trial of universal WBC reduction

Authors
Category Primary study
Year 2002
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. There was no difference in the clinical and cost-effectiveness of white blood cell (WBC)-reduced blood products and non WBC-reduced blood products.
Epistemonikos ID: 9ad4ba1d772a0fe8316e952cd4b3e4783381df4b
First added on: Apr 19, 2023